Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abhinav Vankayalapati"'
Autor:
Fan Yang, Alireza Labani-Motlagh, Jose Alejandro Bohorquez, Josimar Dornelas Moreira, Danish Ansari, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Tsuyoshi Sakai, Osamu Sato, Mitsuo Ikebe, Ramakrishna Vankayalapati, John J. Dennehy, Buka Samten, Guohua Yi
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-13 (2024)
Abstract The continuing emergence of new strains of antibiotic-resistant bacteria has renewed interest in phage therapy; however, there has been limited progress in applying phage therapy to multi-drug resistant Mycobacterium tuberculosis (Mtb) infec
Externí odkaz:
https://doaj.org/article/1ac890637fe24a00b09370f2537cb206
Autor:
Abhinav Vankayalapati, Olamipejo Durojaye, Tanmoy Mukherjee, Padmaja Paidipally, Bismark Owusu-Afriyie, Ramakrishna Vankayalapati, Rajesh Kumar Radhakrishnan
Publikováno v:
PLoS Pathogens, Vol 20, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/a35c3c70164f4f969517f17db99702b3
Autor:
Deepak Tripathi, Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Tanmoy Mukherjee, Padmaja Paidipally, Rajesh Kumar Radhakrishnan, Igor Dozmorov, Abhinav Vankayalapati, Mohammad Soheb Ansari, Varalakshmi Mallidi, Anvesh Kumar Bogam, Karan P. Singh, Buka Samten, Vijaya Lakshmi Valluri, Ramakrishna Vankayalapati
Publikováno v:
JCI Insight, Vol 7, Iss 22 (2022)
To determine the mechanisms that mediate resistance to Mycobacterium tuberculosis (M. tuberculosis) infection in household contacts (HHCs) of patients with tuberculosis (TB), we followed 452 latent TB infection–negative (LTBI–) HHCs for 2 years.
Externí odkaz:
https://doaj.org/article/dfdfd08ec87441319bfc8a3e0a6fb791
Autor:
Fan Yang, Alireza Labani-Motlagh, Josimar Dornelas Moreira, Danish Ansari, Jose Alejandro Bohorquez, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Ramakrishna Vankayalapati, John J. Dennehy, Buka Samten, Guohua Yi
Publikováno v:
bioRxiv
The continuing emergence of new strains of antibiotic-resistant bacteria has renewed interest in phage therapy; however, there has been limited progress in applying phage therapy to multi-drug resistantMycobacterium tuberculosis(Mtb) infections. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45a1d2748d919ace97db1744cccc0ae
https://doi.org/10.2139/ssrn.4382958
https://doi.org/10.2139/ssrn.4382958
